In prostate cancer, plenty of LncRNAs, including PCGEM1[9], SOCS2-AS1[10], PlncRNA-1[11], CTBP1-AS[12], DRAIC and PCAT29[13], have been reported to be associated with AR pathway, and thus act as regulators in the development of PCa. Here, PCGEM1 is linked to posterior cortical atrophy.